Lindbrook Capital, LLC

SEC CIK: 0001767045
Latest filing: May 5, 2025

SEC filings (opens in a new tab)

TCON holding history

Tracon Pharmaceuticals, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCON overview All 13F holders of TCON Full Q1 2025 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of TCON by Lindbrook Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−2,000−100.0%	Sold out	Holders
Q3 2021	2,000	$8.00K	<0.1%	−1,000−33.3%	Reduced	Holders
Q2 2021	3,000	$19.0K	<0.1%	−3,500−53.8%	Reduced	Holders
Q1 2021	6,500	$53.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.